nach oben

Erschienen in:

04.01.2018 | Brief Report

Oxford House Residents’ Attitudes Toward Medication Assisted Treatment Use in Fellow Residents

verfasst von: John M. Majer, Christopher Beasley, Emily Stecker, Ted J. Bobak, Joshua Norris, Hai Minh Nguyen, Maisie Ogata, Jordana Siegel, Brandon Isler, Elzbieta Wiedbusch, Leonard A. Jason

Erschienen in: Community Mental Health Journal | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Methadone and buprenorphine/naloxone are medication assisted treatment (MAT) options for treating opioid use disorder, yet attitudes regarding their use within abstinence-based recovery homes have not been assessed. The present investigation examined attitudes regarding MAT utilization among residents living in Oxford Houses. This cross-sectional investigation compared residents (n = 87) receiving MAT whose recent drug use involved opioids, and two groups not receiving MATs; those who had used opioids and those who had used substances other than opioids. The vast majority of residents were not receiving MAT, yet 32% reported MAT histories. Negative attitudes regarding MAT were observed among residents who were not receiving MAT. Those presently receiving MAT reported mixed attitudes regarding the use of methadone and buprenorphine/naloxone, and two of these residents reported they had never been prescribed MAT. Findings suggest that abstinence-based recovery homes such as Oxford Houses may not be optimal resources for persons receiving MATs.

We used the termed “using addict” in our survey because it is an idiom frequently used by Narcotics Anonymous (NA) members to represent one who is intentionally using substances for the purpose of altering one’s mood/mind. Although we respectfully acknowledge NA members’ use and identification with the term “addict,” we do not condone the use of this term in the pejorative sense.

Bart, G. (2012). Maintenance medication for opiate addiction: the foundation of recovery. Journal of Addictive Diseases, 31(3), 207–225. https://doi.org/10.1080/10550887.2012.694598.CrossRefPubMedPubMedCentral

Bretteville-Jensen, A. L., Lillehagen, M., Gjersing, L., & Andreas, J. B. (2015). Illicit use of opioid substitution drugs: prevalence, user characteristics, and the association with non-fatal overdoses. Drug and Alcohol Dependence, 147, 89–96. https://doi.org/10.1016/j.drugalcdep.2014.12.002.CrossRefPubMed

Center for Behavioral Health Statistics and Quality. (2016). Key substance use and mental health indicators in the United States: Results from the 2015 National Survey on Drug Use and Health (HHS Publication No. SMA 16-4984, NSDUH Series H-51). Retrieved June 26, 2017, from http://www.samhsa.gov/data/.

Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014). The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry, 71, 821–826. https://doi.org/10.1001/jamapsychiatry.2014.366.CrossRefPubMed

Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher-Bartelson, B., & Green, J. L. (2015). Trends in opioid analgesic abuse and mortality in the United States. The New England Journal of Medicine, 372, 241–248. https://doi.org/10.1056/NEJMsa1406143.CrossRefPubMed

Dole, V. P. (1988). Implications of methadone maintenance for theories of narcotic addiction. Journal of the American Medical Association, 260, 3025–3029.CrossRefPubMed

Dole, V. P., & Nyswander, M. E. (1967). Heroin addiction—A metabolic disease. Archives of Internal Medicine, 120, 19–24.CrossRefPubMed

Gowing, L., Ali, R., & White, J. M. (2004). Buprenorphine for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews Issue 4. Art. No.: CD002025.pub2. https://doi.org/10.1002/14651858.CD002025.pub4.

Hasan, M. K., & Hasan, O. K. (2011). Opiate addiction and prescription drug abuse: A pragmatic approach. Journal of the Islamic Medical Association of North America, 43, 23–26. https://doi.org/10.5915/43-1-6509.CrossRef

Hill, D. R., Conroy, S., Afzal, A., Lang, D., Steele, S., & Campbell, D. (2015). A comparison of methadone and buprenorphine-naloxone as opioid substitution therapy: The patient perspective in NHS Lanarkshire. Journal of Substance Use, 20, 168–177. https://doi.org/10.3109/14659891.2014.894589.CrossRef

Jason, L. A., Davis, M. I., Ferrari, J., & Anderson, E. (2007). The need for substance Abuse after-care: Longitudinal analysis of Oxford House. Addictive Behaviors, 32, 803–818. https://doi.org/10.1016/j.addbeh.2006.06.014.CrossRefPubMed

Jason, L. A., Olson, B. D., & Foli, K. (2008). Rescued lives: The Oxford House approach to substance abuse. New York: Routledge.

Johnson, B., & Richert, T. (2015a). Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: Prevalence estimates. International Journal of Drug Policy, 26, 183–190. https://doi.org/10.1016/j.drugpo.2014.10.003.CrossRefPubMed

Johnson, B., & Richert, T. (2015b). Diversion of methadone and buprenorphine from opioid substitution treatment: The importance of patients’ attitudes and norms. Journal of Substance Abuse Treatment, 54, 50–55. https://doi.org/10.1016/j.jsat.2015.01.013.CrossRefPubMed

Kiepek, N., Hancock, L., Toppozini, D., Cromarty, H., Morgan, A., & Kelly, L. (2012). Facilitating medical withdrawal from opiates in rural Ontario. Rural and Remote Health, 12, 2193–2193.PubMed

Majer, J. M., Jason, L. A., Ferrari, J., & Miller, S. A. (2011). 12-step involvement among a U.S. national sample of Oxford House residents. Journal of Substance Abuse Treatment, 41, 37–44. https://doi.org/10.1016/j.jsat.2011.01.010.CrossRefPubMedPubMedCentral

Majer, J. M., Jason, L. A., Ferrari, J., Venable, L. B., & Olson, B. D. (2002). Social support and self-efficacy for abstinence: Is peer identification an issue? Journal of Substance Abuse Treatment, 23, 209–215.CrossRefPubMed

Mercadante, S., Sapio, M., Serretta, R., & Caligara, M. (1996). Patient-controlled analgesia with oral methadone in cancer pain: Preliminary report. Annals of Oncology, 7, 613–617.CrossRefPubMed

Narcotics Anonymous. (2008). Narcotics Anonymous: Basic text (6th edn.). Van Nuys: World Service Office.

Narcotics Anonymous. (2016). Narcotics Anonymous and persons receiving medication-assisted treatment. Retrieved June 26, 2017, from https://www.na.org/admin/include/spaw2/uploads/pdf/pr/2306_NA_PRMAT_1021.pdf.

Oxford House Inc. (2011). Oxford House manual. Silver Springs, MD: Oxford House Inc.

Schwartz, R. P., Kelly, S. M., O’Grady, K. E., Mitchell, S. G., Peterson, J. A., Reisinger, H. S., & Brown, B. S. (2008). Attitudes toward buprenorphine and methadone among opioid-dependent individuals. The American Journal on Addictions, 17, 396–401. https://doi.org/10.1080/10550490802268835.CrossRefPubMedPubMedCentral

Substance Abuse and Mental Health Services Administration. (2011). SAMHSA’s National Registry of Evidence-Based Programs and Practices. Rockville, MD: Author. Retrieved June 26, 2017, from http://www.nrepp.samhsa.gov/ViewIntervention.aspx.

Walters, G. D. (1994). The drug lifestyle: One pattern or several? Psychology of Addictive Behaviors, 8, 8–13.CrossRef

Titel: Oxford House Residents’ Attitudes Toward Medication Assisted Treatment Use in Fellow Residents
verfasst von: John M. Majer
Christopher Beasley
Emily Stecker
Ted J. Bobak
Joshua Norris
Hai Minh Nguyen
Maisie Ogata
Jordana Siegel
Brandon Isler
Elzbieta Wiedbusch
Leonard A. Jason
Publikationsdatum: 04.01.2018
Verlag: Springer US
Erschienen in: Community Mental Health Journal / Ausgabe 5/2018
Print ISSN: 0010-3853
Elektronische ISSN: 1573-2789
DOI: https://doi.org/10.1007/s10597-017-0218-4

Neu im Fachgebiet Psychiatrie

23.04.2024 | Demenz | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Oxford House Residents’ Attitudes Toward Medication Assisted Treatment Use in Fellow Residents

Abstract

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

Correction to: Oxford House Residents’ Attitudes Toward Medication Assisted Treatment Use in Fellow Residents

Association Between Employment and Mental Health Service Use Among Justice-Involved Individuals

Body Image Assessment Among Community Mental Health Providers

Increasing Rate of Psychological Distress in Urban Households: How Does Income Matter?

Assessing Mental Health Among Adults

Associated Factors of Self-Rated Mental Health Status in Southwestern Iran: Using SCAD Regression Model in a Population-Based Study

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie